On the upsideAmylin Pharmaceuticals (Nasdaq: AMLN) requested that the Food and Drug Administration approve its once a week injectable diabetes drug exenatide LAR.
An analyst upgraded MGM Mirage (NYSE: MGM) after the casino operator posted a first quarter profit.
A Bloomberg News article said that AIG (NYSE: AIG) is expected to report a first quarter profit and will most likely not need additional capital from the government.
On the downside
Myriad Genetics (Nasdaq: MYGN) reversed year ago losses to post a profit for the third quarter but revenue misses estimates.
Chesapeake Energy (NYSE: CHK) widened first quarter losses due to a significant write-down.
In the broad market, declining issues outpaced advancers by a margin of 3 to 2 on the NYSE and by nearly 5 to 3 on Nasdaq. The Russell 2000 which tracks small cap lost 7 points to 499.